{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T08:14:30Z","timestamp":1768292070225,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.braindev.2010.03.002","type":"journal-article","created":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T08:39:43Z","timestamp":1270111183000},"page":"145-151","source":"Crossref","is-referenced-by-count":18,"title":["Efficacy and tolerability of levetiracetam in children with epilepsy"],"prefix":"10.1016","volume":"33","author":[{"given":"Jiahui","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2010.03.002_b0005","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2165\/00128072-200305040-00005","article-title":"Pharmacokinetic considerations in the treatment of childhood epilepsy","volume":"5","author":"Gilman","year":"2003","journal-title":"Pediatr Drugs"},{"key":"10.1016\/j.braindev.2010.03.002_b0010","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0163-7258(99)00052-2","article-title":"Pharmacokinetic profile of levetiracetam: toward ideal characteristics","volume":"85","author":"Patsalos","year":"2000","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.braindev.2010.03.002_b0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0920-1211(02)00250-4","article-title":"Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trials","volume":"53","author":"Perucca","year":"2003","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.braindev.2010.03.002_b0020","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1212\/01.wnl.0000217916.00225.3a","article-title":"Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures","volume":"66","author":"Glauser","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2010.03.002_b0025","unstructured":"UCB\/N166 Study. Levetiracetam as add-on treatment of myoclonic jerks in adolescents and adults. ClinicalTrials.gov. Available from: http:\/\/clinicaltrials.gov\/show\/NCT00150774."},{"key":"10.1016\/j.braindev.2010.03.002_b0030","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1528-1157.2000.tb04605.x","article-title":"Efficacy and tolerability of levetiracetam 3000mg\/d in patients with refractory focal seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy","volume":"41","author":"Ben-Menachem","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2010.03.002_b0035","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1212\/WNL.55.2.236","article-title":"Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial","volume":"55","author":"Cereghino","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2010.03.002_b0040","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1528-1157.2000.tb00323.x","article-title":"Multicenter, doubleblind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures","volume":"41","author":"Shorvon","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2010.03.002_b0045","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1528-1157.1981.tb06159.x","article-title":"Proposal for revised clinical and electroencephalographic classification of epileptic seizures","volume":"22","year":"1981","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2010.03.002_b0050","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Proposal for revised classification of epilepsies and epileptic syndromes","volume":"30","year":"1989","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2010.03.002_b0055","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1528-1157.1993.tb02586.x","article-title":"Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935\u201384","volume":"34","author":"Hauser","year":"1993","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2010.03.002_b0060","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1528-1157.1991.tb04675.x","article-title":"Prevalence of epilepsy in Rochester, Minnesota: 1940\u201380","volume":"32","author":"Hauser","year":"1991","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2010.03.002_b0065","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1046\/j.1528-1157.2001.0420081094.x","article-title":"ILAE\u29f9IBE\u29f9WHO Global Campaign \u201cOut of the Shadows\u2019\u2019: global and regional developments","volume":"42","author":"Reynolds","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2010.03.002_b0070","first-page":"344","article-title":"The treatment of epilepsy in developing countries: where do we go from here?","volume":"79","author":"Scot","year":"2001","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.braindev.2010.03.002_b0075","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S1474-4422(04)00882-8","article-title":"Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines","volume":"3","author":"Beghi","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.braindev.2010.03.002_b0080","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1528-1157.2000.tb04605.x","article-title":"Efficacy and tolerability of levetiracetam 3000mg\/day in patients with refractory partial seizures: a multicentre, double-blind, responder selected study evaluating monotherapy","volume":"41","author":"Ben-Menachem","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2010.03.002_b0085","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1528-1167.2005.00329.x","article-title":"Levetiracetam in the treatment of idiopathic generalized epilepsies","volume":"46","author":"Grunewald","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2010.03.002_b0090","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1528-1167.2006.00461.x","article-title":"Onset of action of levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA)","volume":"47","author":"Hermann","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2010.03.002_b0095","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2147\/NDT.S2937","article-title":"Levetiracetam in the treatment of epilepsy","volume":"4","author":"Abou-Khalil","year":"2008","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.braindev.2010.03.002_b0100","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1111\/j.1528-1167.2007.01131.x","article-title":"The antiepileptic drug levetiracetam stabilizes the human epileptic GABAA receptors upon repetitive activation","volume":"48","author":"Palma","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2010.03.002_b0105","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1528-1167.2007.01003.x","article-title":"Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review","volume":"48","author":"Perry","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2010.03.002_b0110","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.seizure.2007.02.004","article-title":"Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy","volume":"16","author":"Grosso","year":"2007","journal-title":"Seizure"},{"key":"10.1016\/j.braindev.2010.03.002_b0115","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/j.1528-1167.2007.01043.x","article-title":"Effect of age and comedication on Levetiracetam pharmacokineties and tolerability","volume":"48","author":"Hirsch","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2010.03.002_b0120","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.seizure.2007.07.001","article-title":"Levetiracetam monotherapy in juvenile myoclonic epilepsy","volume":"17","author":"Sharpe","year":"2008","journal-title":"Seizure"},{"key":"10.1016\/j.braindev.2010.03.002_b0125","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.yebeh.2006.08.008","article-title":"Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy","volume":"10","author":"Weintraub","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.braindev.2010.03.002_b0130","first-page":"l654","article-title":"Double blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures","volume":"66","author":"Glanser","year":"2006","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.braindev.2010.03.002_b0135","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pharmthera.2006.07.005","article-title":"Novel anticonvulsant drugs","volume":"113","author":"Stefan","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.braindev.2010.03.002_b0140","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/adc.2007.106880","article-title":"The new antiepileptic drugs","volume":"92","author":"Macleod","year":"2007","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"10.1016\/j.braindev.2010.03.002_b0145","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/jnnp.2005.064626","article-title":"The long term retention of levetiracetam in a large cohort of patients with epilepsy","volume":"77","author":"Depondt","year":"2006","journal-title":"Neurol Neurosurg Psychiatry"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760410000641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760410000641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T22:12:50Z","timestamp":1558995170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760410000641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0387760410000641"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2010.03.002","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}